Pfizer profit falls, hurt by strong dollar

Pfizer Inc (PFE.N) said on Wednesday its second-quarter earnings fell 19 percent, as the strong dollar crimped revenue across its product line.

The world's largest drugmaker earned $2.26 billion, or 34 cents per share, compared with $2.78 billion, or 41 cents per share, in the year-earlier period.

Excluding special items, the New York-based drugmaker earned 48 cents per share, a penny better than analyst expectations, according to Reuters Estimates.

Pfizer raised its full-year forecast for earnings, excluding items, to a range of $1.90 to $2.00 per share. Previously, it expected $1.85 to $1.95 per share.